Lazma Cream – Melasma is a common skin condition in which light to dark brown or grayish pigmentation develops, mainly on the face, less commonly on forearms and neck, due to overproduction of melanin by the pigment cells, melanocytes.
Melasma is sometimes referred as “The Mask of Pregnancy “as appearance of darkened skin areas is common during pregnancy due to hormonal disturbances.
There are many factors that can trigger melasma including birth control pills, hormonal therapy, cosmetics and anti-seizure medications ,but sun exposure is a major melasma trigger because ultraviolet (UV) light from the sun can increase melanin production.
Lazma Cram is the only FDA-approved melasma treatment with 3 active ingredients, uniquely combined and more effective then treatments containing only two of the ingredients.
Lazma cream is available in 15gm (Pink) and 30gm (Blue) pack sizes
Lazma Cream is a unique triple-combination topical therapy for the short-term (8-week ) Melasma treatment of the dark spots associated with moderate-to-severe facial melasma.
Bio-Labs now introduced Lazma Face wash. Lazma cream treats the Melasma, dark spots and pigmentation, combining it with the Lazma Face wash helps you to regain the glow of your skin and getting rid of the dark spots. Using Lazma face wash twice provides acne-free skin, removes excessive oil off your face without skin looking dry or stretchy.
Start your skincare journey with Lazma Facewash. It is enriched with Salicylic Acid, Vitamin E, and the super skin food Aloe Vera gel. Aloe Vera keeps the skin hydrated and helps with rapid healing and preventing ageing, infections, acne, and sunburn. This gentle formula facewash cleanses the skin pores, tones it, and leaves behind hydrated skin. Flaunt a healthy radiance around the clock by using Lazma Face wash twice daily.
Indication: LAZMA Cream is indicated for the short‐term (up to 8 weeks) treatment of moderate to severe melasma of the face in the presence of measures for sun avoidance, including the use of sunscreens.Adverse Events: In the controlled clinical trials, the most frequently reported events were redness, peeling, burning, dryness, and itching at the site of application.